Profound Medical (PROF)
(Delayed Data from NSDQ)
$7.73 USD
-0.79 (-9.27%)
Updated May 10, 2024 04:00 PM ET
After-Market: $7.75 +0.02 (0.26%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
PROF 7.73 -0.79(-9.27%)
Will PROF be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PROF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PROF
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Tops Revenue Estimates
Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer
PROF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?
How Much Upside is Left in Profound Medical (PROF)? Wall Street Analysts Think 66.06%
Other News for PROF
Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
Profound Medical GAAP EPS of $0.26 beats by $0.57, revenue of $1.91M misses by $0.59M
Profound Medical Forecasts Robust Growth in 2024